As of 12:52pm ET
| -0.15 / -9.68%|
The 2 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +614.29% increase from the last price of 1.40.
The current consensus among 2 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.